Target intelligence / Profile preview

Hydrogen cyanide synthase (HCN synthase)

Target
HCN synthase
Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Hydrogen cyanide synthase (HCN synthase) is a membrane-bound enzyme complex, primarily composed of HcnA, HcnB, and HcnC subunits, that catalyzes the oxidative decarboxylation of glycine to generate hydrogen cyanide (HCN) and carbon dioxide. This process, known as cyanogenesis, is a major virulence factor in various pathogenic bacteria, most notably Pseudomonas aeruginosa, which colonizes the respiratory tract of patients with cystic fibrosis. In these settings, biogenically produced HCN acts as a potent toxin that inhibits host mitochondrial respiration by binding to cytochrome c oxidase and facilitates microbial dominance by poisoning competing bacteria such as Staphylococcus aureus. Beyond its role in bacterial virulence, recent research has characterized HCN as a mammalian gasotransmitter produced endogenously to regulate cellular bioenergetics, signal transduction via NMDA receptors, and response to hypoxia. Pathologically elevated HCN production is observed in metabolic conditions like non-ketotic hyperglycinemia, where excessive glycine stimulates cyanogenesis, leading to neurotoxicity. Targeting the HCN synthase complex offers a novel therapeutic approach for anti-virulence strategies, potentially reducing the pathogenicity of multidrug-resistant infections without the strong selective pressure associated with conventional bactericidal antibiotics.

Other names
HcnABC complexGlycine dehydrogenase (cyanide-forming)Cyanide synthaseHydrogen cyanide synthase subunit HcnAHydrogen cyanide synthase subunit HcnBHydrogen cyanide synthase subunit HcnC
02

Mechanism of action

Inhibition of the HcnABC enzyme complex to prevent the oxidative decarboxylation of glycine into volatile hydrogen cyanide.

03

Biological functions

CyanogenesisSecondary metabolismVirulence factor productionGasotransmitter signalingMicrobial competitionApoptosis induction
04

Disease associations

InfectionCystic fibrosisNon-ketotic hyperglycinemiaNeurological diseaseInflammation
05

Safety considerations

Potential interference with mammalian endogenous cyanide signalingRequirement for selective inhibition of bacterial versus host pathwaysEnvironmental toxicity of hydrogen cyanide as a metabolic byproductBacterial adaptation to respiratory toxins
06

Interacting drugs

Pyrrolnitrin

3 more in the full profile.

07

Biomarkers

Exhaled breath hydrogen cyanideSputum cyanide concentrationBlood cyanide levels

Beyond the preview

Go deeper on Hydrogen cyanide synthase (HCN synthase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrogen cyanide synthase (HCN synthase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call